Sirius Genomics this week announced the promotion of Chris Wagner as its president and CEO. Wagner, previously VP of business development at Sirius, will replace Brad Popovich.
Before joining Sirius two years ago, Wagner was VP of marketing and VP of business development at Aspreva. He also held various positions at Eli Lilly.
Popovich will continue as a member of Sirius's board of directors.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
